Table.

Demographic and clinical characteristics of the subjects included in the comparison of vascular features under different experimental conditions

	Vascular Experimental Condition
Characteristic	Basal	4-hour Constriction	18-hour Constriction
Number of Subjects	23	8	12
Age (years)	43.7 ± 2.2	55.5 ± 5.2	40.8 ± 3.1
BMI (Kg/m2)	48.2 ± 1.2	44.6 ± 4.3	40.4 ± 3.4
Sex (females/males)	19/5	7/1	9/3
Non-Diabetics / Diabetics	24/0	6/2	5/7
Non-Hypertensives / Hypertensives	15/8	3/5	9/3
Medications	Albuterol, Alprazolam, Amlodipine, Aripiprazole, Aspirin, Atorvastatin, Bifidobacterium, Bimatoprost, Canagliflozin, Carvedilol, Celecoxib, Cetirizine, Cholecalciferol, Chondroitin, Citalopram, Clopidogrel, Cyanocobalamin, Cyclobenzaprine, Diphenhydramine, Enalapril, Ergocalciferol, Flurosemide, Fluticasone, Folic acid, Glargine, Glimepiride, Glucosamine, Hydrochlorothiazide, Ibuprofen, Insulin, Lactobacillus, Lisinopril, Lisonopril, Lispro, Loratadine, Lorazepam, Losartan, Lovastatin, Lutein, Metformin, Methotrexate, Methylsulfonylmethane, Metoprolol, Metronidazole, Neomycin, Nitroglycerin, Omeprazole, Oxycodone, Pantoprazole, Paroxetine, Polyethylene glycol, Propranolol, Psyllium, Ranitidine, Rosuvastatin, Sertraline, Sitagliptin, Spironolactone, Tiotropium, Tramadol, Triamterene, Verapamil, Zonisamide